Single ascending dose study of the safety, tolerability, and pharmacokinetics of FXR-450 administered orally to healthy Japanese male subjects.
Latest Information Update: 28 Oct 2010
At a glance
- Drugs Turofexorate isopropyl (Primary)
- Indications Lipid metabolism disorders
- Focus Adverse reactions
- 18 Aug 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 21 Jun 2010 Planned number of patients added to 56 as reported by ClinicalTrials.gov.
- 21 Jun 2010 Actual end date (Feb 2008) added as reported by ClinicalTrials.gov.